Skip to main content
Log in

Therapeutic evaluation on advanced pancreatic cancer Treated by Integrative Chinese and western medicine — Clinical analysis of 56 cases

  • Original Articles
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective:In comparison with chemotherapy, to evaluate therapeutic effects on advanced pancreatic cancer treated by integrative Chinese and western medicine (ICWM) therapies.Methods: Based on the retrospective study of 56 patients with advanced pancreatic cancer, life table was applied to the analysis of patients’ survival rate and χ2 test to the comparison of therapeutic response between ICWM and chemotherapy groups.Results: The results showed that 1-year survival rate in the ICWM group was 55. 37%±3.24%; 2-year survival rate 34. 61%±16. 31%; 3-year survival rate 25. 96%±24. 64%; 5-year survival rate 2596%±24.64%; and median survival period 16.3 months. However 1-year survival rate in the chemotherapy group was 21. 95%±27. 54%; 2-year survival rate 7. 31%±27. 54%; 3-year survival rate 0%; and median survival period 7. 5 months. The therapeutic effects between two groups were significantly different (P=0. 004). Further analysis suggested that the reduction of cancer mass in the ICWM group was more than that in chemotherapy group (P=0.049) and the improvement of advanced pancreatic cancer related-symptoms better than that of chemotherapy group (P = 0. 002).Conclusion: The ICWM comprehensive therapy is of important value in the treatment of advanced pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. SHEN K, HE SG, TENG RZ, et al. Strive to elevate the diagnostic and therapeutic level of pancreatic cancer. Clinical Surg 1994; 9 (6): 321–322.

    Google Scholar 

  2. Hermreck AS, Thomas EY, Friesen SR, et al. Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas. Am J Surg 1974; 127: 653–656.

    Article  PubMed  CAS  Google Scholar 

  3. YU ZH. Pancreatic cancer. Tumor Radiotherapeutics. Beijing: Union Press of Beijing Medical University and Chinese Union Medical University, 1993: 595–596.

    Google Scholar 

  4. WU ZH. Pancreas and peri-ampulla tumor. Refer to TANG ZY chief edited. Modern Oncology. Shanghai: Shanghai Medical University Press, 1994: 862–866.

    Google Scholar 

  5. SHEN K, HE SG, TIAN YL, et al. Specialists symposium: Progress on diagnosis and treatment of pancreatic cancer. Chin J Prac Surg 1995; 15 (4): 227–229.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu-ming, L., Liang-cun, W., Sheng-you, L. et al. Therapeutic evaluation on advanced pancreatic cancer Treated by Integrative Chinese and western medicine — Clinical analysis of 56 cases. Chin. J. Integr. Med. 9, 39–43 (2003). https://doi.org/10.1007/BF02836354

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02836354

Key Words

Navigation